Navigation Links
Mr. Ronald L. Chez Filed Amended 13D for RepliGen Corporation
Date:6/22/2011

CHICAGO, June 22, 2011 /PRNewswire/ -- Amended 13D for RepliGen Corporation was filed with the SEC by Mr. Ronald L. Chez, a private investor.

Mr. Ronald L. Chez is the President of Ronald L. Chez, Inc., and a private investor.

RepliGen Corporation is a biopharmaceutical company focused on building an integrated company by developing and marketing innovative drugs that deliver the benefits of protein therapies in the fields of neurology and gastroenterology.  RepliGen has a core competency in the development and manufacturing of biologics products, which is the basis for its bioprocessing business and RepliGen has out-licensed certain biologics intellectual property, which provide ongoing sources of revenue. Corporate headquarters are located at 41 Seyon Street, Waltham, Massachusetts 02453.

Inquiry Contact:
Barry Fischer
(312) 580-2233


'/>"/>
SOURCE Ronald L. Chez
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Cardiac Science Appoints Healthcare Executive Ronald A. Andrews, Jr. to Board of Directors
2. Keppra XR(TM) Extended-Release Tablets Filed with the FDA
3. Parker Waichman Alonso LLP and Affiliated Lawfirms Have Filed a Class Action Lawsuit in the United States District Court for the Eastern District of New York Against Merck & Co., Inc. and Schering-Plough Corporation
4. Shareholder Class Action Filed Against Vertex Pharmaceuticals Incorporated by the Law Firm of Schiffrin Barroway Topaz & Kessler, LLP
5. Shareholder Class Action Filed Against Rigel Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
6. Shire has Filed a Treatment Protocol for Velaglucerase Alfa for Gaucher Disease
7. Shareholder Class Action Filed Against SciClone Pharmaceuticals, Inc. by the Law Firm of Barroway Topaz Kessler Meltzer & Check, LLP
8. Class Action Lawsuit Filed Against DePuy Orthopaedics, Inc.
9. DePuy Recalled Hip Device Lawsuit Filed in East Texas
10. DePuy Recalled Hip Device Lawsuit Filed in San Antonio, Texas
11. DePuy Recalled Hip Device Lawsuit Filed in Austin, Texas
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has announced ... report to their offering. ... a favourable commercial environment for MedImmune to enter. The US ... will serve to drive considerable growth for effective anti-influenza medications. ... cap sales considerably, but development is still in its infancy. ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
(Date:6/23/2016)... , June 23, 2016  Astellas today announced the establishment of Astellas Farma Colombia (AFC), a new affiliate ... in Latin America . ... ... ... ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ProSlice Levels, a ... can give their videos a whole new perspective by using the title layers ... Film Studios. , ProSlice Levels contains over 30 Different presets to choose from. ...
(Date:6/26/2016)... ... June 26, 2016 , ... ... have been diagnosed with endometriosis. These women need a treatment plan to not ... comprehensive approach that can help for preservation of fertility and ultimately achieving a ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
Breaking Medicine News(10 mins):